Dr. William Russell specializes in radiation oncology in Baton Rouge. He graduated from the University of Mississippi School of Medicine in 1984. Russell is double-board certified in internal medicine ...

Don Bryant, Indiana resident, U.S. Army veteran, and prostate cancer survivor who received treatment with Pluvicto™ therapy in clinical trial Philip Low, Purdue Institute for Cancer Research member, ...

Some prostate cancer patients are “missing out” on vital, life-saving treatment, a charity has warned. Thirty-one per cent of men in England with aggressive but curable prostate cancer are missing out ...

Screening for prostate cancer becomes more complex in men over the age of 70. The US Preventive Services Task Force (USPSTF) currently recommends against routine PSA testing in this age group. The PSA ...

Treatment choice for localized prostate cancer depends on cancer aggressiveness and quality-of-life factors, such as sexual functioning. Active surveillance is a safe option for appropriate patients, ...